NCT04049773 (FatHoM) is a clinical trial of haemodialysis in Fatigue, sponsored by Zuyderland Medisch Centrum.

Who is sponsoring NCT04049773?

NCT04049773 is sponsored by Zuyderland Medisch Centrum.

What drugs are being tested in NCT04049773?

Interventions in NCT04049773: haemodialysis.

What condition does NCT04049773 study?

NCT04049773 studies Fatigue, End Stage Renal Disease.

Is NCT04049773 still recruiting?

NCT04049773 is currently completed. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04049773: FatHoM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fatigue in Chronic Haemodialysis Patients: an Experience Sampling Method Study

Completed Last updated 5 February 2020

What this trial tests

trial testing haemodialysis in Fatigue in 42 participants. Completed in 31 December 2019.

Timeline

15 July 2019

Primary endpoint
22 August 2019

31 December 2019

Quick facts

Lead sponsor	Zuyderland Medisch Centrum
Status	Completed
Study type	OBSERVATIONAL
Enrollment	42
Start date	15 July 2019
Primary completion	22 August 2019
Estimated completion	31 December 2019
Sites	2 locations across Netherlands

Drugs / interventions tested

haemodialysis

Conditions studied

Fatigue — all drugs for Fatigue →
End Stage Renal Disease — all drugs for End Stage Renal Disease →

Sponsor

Zuyderland Medisch Centrum — full company profile →

Who can join

18 and older, any sex, with Fatigue or End Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the course and diurnal change of fatigue symptoms and haemodialysis related symptoms in chronic haemodialysis patients, its relation to haemodialysis treatment and the association with other factors by implementing an ecological momentary assessment procedure incorporated in a webapplication.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

mHealth-based experience sampling method to identify fatigue in the context of daily life in haemodialysis patients.
Brys ADH, Stifft F, Van Heugten CM, Bossola M, et al · · 2021 · cited 12× · PMID 33564425 · DOI 10.1093/ckj/sfaa124

Verify or expand the search:

Other trials of haemodialysis

Trials testing the same drug.

NCT06500663 — Studying Thyroid Function of Haemodialysis Patients in Upper Egypt (Two Centers Study). · not yet recruiting
NCT06401122 — Comparison of Dyslipidemia Among Diabetics Versus Non Diabetics in Haemodialysis Patients · not yet recruiting
NCT05274685 — Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome? · NA · completed
NCT04011254 — Haemodialysis fMRI Salt Appetite Study · unknown

Other recruiting trials for Fatigue

Currently open trials in the same condition.

NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
NCT06819254 — Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors · Phase 4 · recruiting

Other Zuyderland Medisch Centrum trials

Trials by the same sponsor.

NCT06896812 — A Pilot Study on App-based Treatment Combining Physical Exercise, Graded Activity, and Pain Journaling for Patients with · NA · not yet recruiting
NCT05941351 — fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma · NA · not yet recruiting
NCT06219018 — Effect of Honey For CIN II · Phase 1, PHASE2 · recruiting
NCT06827834 — Spinal Cord Monitoring in Multiple Sclerosis · recruiting
NCT06381518 — Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04049773 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zuyderland Medisch Centrum
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04049773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing